Procter & Gamble Stock Has Outperformed The S&P 500 Since 2017 End: Here’s Why
Procter & Gamble (NYSE: PG) stock price gained almost 50% from around $92 at 2018 end to $135 currently, primarily due to favorable changes in its revenues and P/S multiple. Additionally, the company witnessed a steady rise in its revenue per share, helped by a drop in the outstanding share count. The stock’s gains have helped PG outperform the S&P, which returned a little under 40% over the same period.
In our interactive dashboard, Why Procter & Gamble Stock Moved: PG Stock Has Gained 47% Since 2017, we break down the factors behind this move.
(A) PG’s Total Revenue has risen 20% from $66.8 billion in FY 2018 to $80.2 billion currently
- PG’s total revenue has risen steadily from $66.8 billion in FY ’18 to $80.2 billion in FY ’22 (PG’s fiscal year ends in June), and currently stands at around the same level.
- As of FY ’22, PG’s largest segment is Fabric & Home Care, contributing $27.6 billion to total sales, bringing in almost 35% of the company’s revenues.
- Besides this, the health care segment has been the fastest growing segment, with sales rising around 20% between FY ’20 and FY ’22, standing at almost $11 billion as of FY ’22.
- For details about PG revenues and comparison to peers, see Procter & Gamble (PG) Revenue Comparison
- Should You Buy Colgate-Palmolive Stock At $80?
- Here’s A Better Pick Over Procter & Gamble Stock
- Should You Buy This Households & Personal Products Company Over Colgate-Palmolive Stock?
- This Pharmaceuticals Company Looks To Be A Better Pick Over Procter & Gamble Stock
- Consistent Sales Growth Has Helped Procter & Gamble Stock To Match The Market Returns
- Despite Steady Gains, Procter & Gamble Stock Has Underperformed The S&P 500 Since 2018
(B) Revenue per share (RPS) increased 27% from $25.70 in FY 2018 to $32.58 currently
- PG revenue rose from $66.8 billion in 2018 to $80.2 billion currently, while the outstanding share count dropped from 2.6 billion in 2018 to 2.5 billion currently.
- Due to this, RPS has risen steadily from $25.70 in FY ’18 to $32.58 currently.
(C) Price-To-Sales (P/S) multiple for PG rose strongly from 3.3x in 2017 to 5.1x by 2021 end but has pulled back to 4.1x currently, still almost 1.3x higher than its 2017 level
- PG’s P/S multiple rose strongly to around 5.1x by late 2021, on the back of rising investor expectations surrounding continued demand growth for its products across all markets, leading to a rise in the company’s sales.
- However, due to the increased economic uncertainty weighing on the broader markets, the P/S multiple has pulled back, currently standing at around 4.1x.
- For additional details about the company stock returns and comparison to peers, see Procter & Gamble (PG) Stock Return Comparison.
What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.
|S&P 500 Return||-7%||-23%||64%|
|Trefis Multi-Strategy Portfolio||-11%||-25%||196%|
 Month-to-date and year-to-date as of 9/23/2022
 Cumulative total returns since the end of 2016
Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates